Literature DB >> 3105692

Eczema herpeticum: a potentially fatal disease.

I R Sanderson, L A Brueton, M O Savage, J I Harper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3105692      PMCID： PMC1245744          DOI： 10.1136/bmj.294.6573.693

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  5 in total

1.  The clinical vagaries of the herpes virus.

Authors:  R T BRAIN
Journal:  Br Med J       Date:  1956-05-12

2.  9-(2-hydroxyethoxymethyl) guanine activity against viruses of the herpes group.

Authors:  H J Schaeffer; L Beauchamp; P de Miranda; G B Elion; D J Bauer; P Collins
Journal:  Nature       Date:  1978-04-13       Impact factor: 49.962

3.  Treatment of eczema herpeticum with systemic acyclovir.

Authors:  J C Jawitz; H C Hines; A N Moshell
Journal:  Arch Dermatol       Date:  1985-02

4.  Eczema herpeticum, primary and recurrent.

Authors:  C E Wheeler; D C Abele
Journal:  Arch Dermatol       Date:  1966-02

5.  Treatment of eczema herpeticum with acyclovir.

Authors:  R N Swart; B J Vermeer; J W van Der Meer; F A Enschedé; J Versteeg
Journal:  Arch Dermatol       Date:  1983-01
  5 in total
  6 in total

1.  Comorbidity in Atopic Dermatitis.

Authors:  Eric L Simpson
Journal:  Curr Dermatol Rep       Date:  2012-03-01

2.  Cathelicidin deficiency predisposes to eczema herpeticum.

Authors:  Michael D Howell; Andreas Wollenberg; Richard L Gallo; Michael Flaig; Joanne E Streib; Cathy Wong; Tatjana Pavicic; Mark Boguniewicz; Donald Y M Leung
Journal:  J Allergy Clin Immunol       Date:  2006-02-14       Impact factor: 10.793

3.  [Eczema herpeticum: Pathogenesis and therapy].

Authors:  H C Rerinck; S Kamann; A Wollenberg
Journal:  Hautarzt       Date:  2006-07       Impact factor: 1.198

Review 4.  [Eczema herpeticatum].

Authors:  S Wetzel; A Wollenberg
Journal:  Hautarzt       Date:  2004-07       Impact factor: 1.198

Review 5.  Infection and prevention: current controversies in childhood atopic eczema: a review.

Authors:  T J David
Journal:  J R Soc Med       Date:  1989-07       Impact factor: 18.000

6.  Interleukin-36β provides protection against HSV-1 infection, but does not modulate initiation of adaptive immune responses.

Authors:  Katelynn A Milora; Siva R Uppalapati; Julio C Sanmiguel; Wei Zou; Liselotte E Jensen
Journal:  Sci Rep       Date:  2017-07-19       Impact factor: 4.379
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.